The HLA Hypersensitivity to Abacavir B*5701 Test is a genetic screening designed to identify individuals who are at risk of developing a hypersensitivity reaction to abacavir, a medication commonly used in the treatment of HIV. This hypersensitivity reaction can be severe and potentially life-threatening, making it crucial to identify at-risk individuals before the initiation of abacavir treatment.
The test specifically looks for the presence of the HLA-B*5701 allele, a genetic variant strongly associated with an increased risk of abacavir hypersensitivity. By detecting this allele, healthcare providers can make informed decisions regarding the suitability of abacavir for their patients, thus significantly reducing the risk of adverse reactions.
Offered at DNA Labs UAE, the HLA Hypersensitivity to Abacavir B*5701 Test is priced at 1400 AED. Conducted in a state-of-the-art laboratory setting, the test provides accurate and reliable results, ensuring that patients receive the safest and most effective care tailored to their genetic profile.
The HLA Hypersensitivity to Allopurinol B*5801 Test is a specialized diagnostic assessment designed to identify individuals at increased risk of developing severe adverse reactions to allopurinol, a medication commonly used to treat gout and certain types of kidney stones. This test is particularly crucial as it screens for the presence of the HLA-B*5801 allele, a genetic variant associated with a heightened sensitivity to allopurinol, leading to potentially life-threatening conditions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test ensures precision and reliability in results. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the specific HLA-B*5801 allele. The presence of this allele can significantly influence the course of treatment for individuals requiring allopurinol, guiding healthcare providers to consider alternative medications or adjust dosages accordingly to mitigate the risk of severe reactions.
The cost of the HLA Hypersensitivity to Allopurinol B*5801 Test at DNA Labs UAE is 1400 AED, an investment in personalized medicine that can greatly enhance patient safety and treatment efficacy. By identifying genetic predispositions to drug hypersensitivity, this test represents a critical step forward in the field of pharmacogenomics, offering a tailored approach to medication management and reducing the likelihood of adverse drug reactions.
The HLA Hypersensitivity to Carbamazepine and Phenytoin B*1502 Test is a specialized diagnostic assessment designed to identify individuals who are at an increased risk of developing severe hypersensitivity reactions to the anticonvulsant medications carbamazepine and phenytoin. This test is particularly crucial for patients who are being considered for therapy with these drugs, as it helps in guiding clinicians to make safer prescription choices. The test works by detecting the presence of the HLA-B*1502 allele, a genetic marker strongly associated with an increased risk of adverse reactions to these medications in certain populations, particularly those of Asian descent.
Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing services, the test ensures accuracy and reliability in results. The cost of the HLA Hypersensitivity to Carbamazepine and Phenytoin B*1502 Test is 1400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. This test represents a crucial step towards personalized medicine, enabling healthcare providers to tailor treatments to the genetic profiles of their patients, thus minimizing the risk of drug-induced hypersensitivity reactions and enhancing patient safety.
The "Immunosuppressant Drug Profile 3 Test" is a specialized medical test designed to monitor and measure the levels of specific immunosuppressive drugs in the bloodstream. This test is particularly important for individuals who have undergone organ transplantation or are being treated for autoimmune diseases, as it helps in ensuring that the dosage of immunosuppressant medications is optimal to prevent organ rejection while minimizing potential side effects. The test can analyze the concentration of various immunosuppressant drugs, aiding healthcare providers in adjusting medication dosages for effective treatment management.
Performed at DNA Labs UAE, a reputable laboratory known for its advanced diagnostic solutions and accurate testing services, this test offers a reliable assessment for patients undergoing immunosuppressive therapy. The cost of the "Immunosuppressant Drug Profile 3 Test" is set at 1400 AED, reflecting the sophisticated nature of the analysis and the valuable insights it provides for personalized patient care. By availing of this test at DNA Labs UAE, patients and healthcare providers can work together more effectively to manage complex conditions requiring immunosuppression, ensuring better health outcomes and improved quality of life.
The Metanephrines Fractionated Random Urine Test is a diagnostic examination aimed at measuring the levels of metanephrines in the urine. Metanephrines are metabolites produced when the body breaks down catecholamines such as adrenaline and noradrenaline, hormones involved in the body's stress response and regulation of blood pressure. This test is particularly crucial in diagnosing and monitoring conditions related to abnormal catecholamine production, such as pheochromocytoma or paraganglioma, which are types of tumors that can affect the adrenal glands.
Performed at DNA Labs UAE, the test involves collecting a random urine sample from the patient, which is then analyzed to determine the concentration of metanephrines. The cost of the test is set at 1400 AED. This test is valuable for its non-invasive nature, providing critical insights into the body's catecholamine metabolism without the need for more invasive procedures. Patients undergoing this test at DNA Labs UAE can expect professional handling of their samples and accurate, reliable results that can guide further diagnostic or therapeutic steps.
The Metanephrines Fractionated 24 Hour Urine Test is a diagnostic procedure performed to measure the levels of metanephrines (metanephrine and normetanephrine) in the urine over a 24-hour period. Metanephrines are metabolites produced when the body breaks down catecholamines, such as adrenaline and noradrenaline, hormones that are released by the adrenal glands during stress. This test is crucial for diagnosing and monitoring conditions related to excessive catecholamine production, most notably pheochromocytoma and paraganglioma, which are types of tumors that can affect the adrenal glands.
The test involves collecting all urine produced in a 24-hour period in a provided container and returning it to the laboratory for analysis. This comprehensive approach ensures a more accurate assessment of metanephrine levels, as these can fluctuate throughout the day.
At DNA Labs UAE, the cost of the Metanephrines Fractionated 24 Hour Urine Test is set at 1400 AED. DNA Labs UAE is a leading diagnostic center known for its advanced testing facilities and commitment to providing accurate and timely results. Their state-of-the-art laboratory is equipped with the latest technology to ensure high precision in test results, making them a reliable choice for patients needing this specific diagnostic test.
The Metanephrines Free Plasma Test is a specialized diagnostic procedure designed to measure the levels of metanephrines in the blood. Metanephrines are metabolites produced from the breakdown of catecholamines, such as adrenaline and noradrenaline, hormones that play crucial roles in the body's stress response and regulation of blood pressure. This test is particularly important in the diagnosis and monitoring of pheochromocytomas and paragangliomas, which are rare tumors that can secrete excessive amounts of catecholamines, leading to potentially life-threatening symptoms.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic technologies and professional expertise, the Metanephrines Free Plasma Test ensures high accuracy and reliability. The test is priced at 1400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it provides into the patient's metabolic status and potential endocrine disorders. Patients undergoing this test at DNA Labs UAE can expect a seamless experience, with guidance and support provided by experienced healthcare professionals throughout the testing process.
The Myotonic Dystrophy Type 1 Test is a specialized genetic test designed to diagnose Myotonic Dystrophy Type 1 (DM1), a form of muscular dystrophy characterized by muscle weakness and myotonia. This condition is caused by a mutation in the DMPK gene, where a segment of DNA is abnormally expanded. The test involves analyzing a sample of the patient's DNA to detect the presence and size of the CTG triplet repeat expansion in the DMPK gene, which is responsible for the condition.
Administered at DNA Labs UAE, a leading facility in genetic testing, the Myotonic Dystrophy Type 1 Test is essential for accurate diagnosis and management of the disorder. It aids in confirming the diagnosis, understanding the severity of the condition, and guiding treatment decisions. Additionally, it can be useful for family planning and determining the risk of passing the condition to offspring.
The cost of the Myotonic Dystrophy Type 1 Test at DNA Labs UAE is set at 1400 AED. Given the complexity of the condition and the specialized nature of the test, this price reflects the comprehensive analysis and the detailed report provided by the lab. Individuals seeking this test can expect a reliable service backed by the expertise of DNA Labs UAE, ensuring accurate and timely diagnosis of Myotonic Dystrophy Type 1.
The "Warfarin Therapeutic Response Predictive Assay VKORC1 and CYP2C9 Test" is a specialized genetic test offered by DNA Labs UAE, priced at 1280 AED. This diagnostic tool is designed to evaluate an individual's genetic predisposition to respond to warfarin, a commonly prescribed anticoagulant medication used to prevent blood clots. The test focuses on analyzing specific genetic variants in two genes: VKORC1 and CYP2C9.
The VKORC1 gene encodes for a protein that is a key target of warfarin, while the CYP2C9 gene is involved in the metabolism of the drug. Variations in these genes can significantly affect how a person metabolizes warfarin, impacting the drug's efficacy and risk of side effects. By identifying these genetic variants, healthcare providers can tailor warfarin dosing to the individual's genetic makeup, enhancing treatment safety and effectiveness. This personalized approach to medication management aims to minimize the risk of bleeding complications or thrombosis, ensuring optimal therapeutic outcomes for patients on warfarin therapy.
The Factor V Leiden Detection RNA Qualitative Test is a specialized diagnostic procedure designed to identify the presence of the Factor V Leiden mutation, a genetic variation that can significantly increase the risk of developing abnormal blood clots. This test specifically targets and analyzes RNA to detect the mutation, offering a qualitative assessment, meaning it determines whether the mutation is present or not, without quantifying the amount of mutated gene.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for individuals with a family history of blood clotting disorders or those who have experienced unexplained thrombotic events. By identifying the mutation, healthcare providers can tailor treatment and management plans to reduce the risk of clot-related complications.
The cost of the Factor V Leiden Detection RNA Qualitative Test at DNA Labs UAE is set at 1200 AED. This investment in health allows individuals to take proactive steps in managing their well-being, particularly in preventing potentially life-threatening conditions associated with the Factor V Leiden mutation.
